EP1230353A4 - Bifunctional molecules and their use in the disruption of protein-protein interactions - Google Patents

Bifunctional molecules and their use in the disruption of protein-protein interactions

Info

Publication number
EP1230353A4
EP1230353A4 EP20000980512 EP00980512A EP1230353A4 EP 1230353 A4 EP1230353 A4 EP 1230353A4 EP 20000980512 EP20000980512 EP 20000980512 EP 00980512 A EP00980512 A EP 00980512A EP 1230353 A4 EP1230353 A4 EP 1230353A4
Authority
EP
European Patent Office
Prior art keywords
protein
disruption
bifunctional molecules
interactions
protein interactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20000980512
Other languages
German (de)
French (fr)
Other versions
EP1230353A1 (en
Inventor
Gerald R Crabtree
Kryn Stankunas
Roger Briesewitz
Thomas Wandless
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of EP1230353A1 publication Critical patent/EP1230353A1/en
Publication of EP1230353A4 publication Critical patent/EP1230353A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
EP20000980512 1999-11-19 2000-11-17 Bifunctional molecules and their use in the disruption of protein-protein interactions Withdrawn EP1230353A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16667599P 1999-11-19 1999-11-19
US166675P 1999-11-19
PCT/US2000/031695 WO2001036612A1 (en) 1999-11-19 2000-11-17 Bifunctional molecules and their use in the disruption of protein-protein interactions

Publications (2)

Publication Number Publication Date
EP1230353A1 EP1230353A1 (en) 2002-08-14
EP1230353A4 true EP1230353A4 (en) 2002-11-06

Family

ID=22604262

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20000980512 Withdrawn EP1230353A4 (en) 1999-11-19 2000-11-17 Bifunctional molecules and their use in the disruption of protein-protein interactions

Country Status (3)

Country Link
EP (1) EP1230353A4 (en)
AU (1) AU1776501A (en)
WO (1) WO2001036612A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2044001A (en) 1999-11-19 2001-05-30 Board Of Trustees Of The Leland Stanford Junior University Targeted bifunctional molecules and therapies based thereon
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
WO2016112295A1 (en) 2015-01-09 2016-07-14 Warp Drive Bio, Inc. Compounds that participate in cooperative binding and uses thereof
WO2017059207A1 (en) 2015-10-01 2017-04-06 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
KR102615448B1 (en) 2016-04-12 2023-12-19 징코 바이오웍스, 인크. Compositions and methods for the production of compounds
CA3042231A1 (en) 2016-10-28 2018-05-03 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
WO2021091967A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
TW202132314A (en) 2019-11-04 2021-09-01 美商銳新醫藥公司 Ras inhibitors
BR112022008565A2 (en) 2019-11-04 2022-08-09 Revolution Medicines Inc COMPOUND, PHARMACEUTICAL COMPOSITION, CONJUGATE, METHODS TO TREAT CANCER AND A RAS PROTEIN-RELATED DISORDER
MX2023003060A (en) 2020-09-15 2023-04-05 Revolution Medicines Inc Indole derivatives as ras inhibitors in the treatment of cancer.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061055A1 (en) * 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1978095A1 (en) * 1993-02-12 2008-10-08 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptor proteins for controlling signal transduction and ligands binding thereto

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061055A1 (en) * 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0136612A1 *

Also Published As

Publication number Publication date
EP1230353A1 (en) 2002-08-14
WO2001036612A1 (en) 2001-05-25
AU1776501A (en) 2001-05-30

Similar Documents

Publication Publication Date Title
HK1084109A1 (en) 2-,3-,4-,or 5-substituted-n1-(benzensulfonyl) indoles and their use in therapy 2-
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
IL205242A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
GB9721437D0 (en) Heteroaromatic compounds and their use in medicine
HK1039637A1 (en) Heteroduplex mutational vectors and use thereof in bacteria
HU9902952D0 (en) Water-soluble pharmaceutical copositions in an ionic complex and the use thereof
HUP0101137A3 (en) Anticoagulant amidines and their pharmaceutical use
PT1212317E (en) INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF OSTEOPOROSIS BETWEEN OTHER APPLICATIONS
AU4196801A (en) Chordin-like-2 molecules and uses thereof
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
HUP0203811A3 (en) Use of polymeric material in the treatment of hard surfaces
EP1230353A4 (en) Bifunctional molecules and their use in the disruption of protein-protein interactions
EP1147213A4 (en) Novel rgs-containing molecules and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
GB2352234B (en) Improvements in and relating to portable disc holders
AU2001266229A1 (en) Hcn polypeptides and polynucleotides and their use in therapy
GB2370233B (en) Apparatus for use in behaviour modification and the like
IL142778A0 (en) Therapeutic product and its use
PL363048A1 (en) Azabicyclic derivatives and their therapeutic use
AU2001277119A1 (en) Human kininogen d5 domain polypeptides and their use
FI964809A0 (en) In the case of use of the processing unit
ZA981782B (en) The use of levobupivacaine in combination with other drugs
GB2336582B (en) Improvements in storage and display devices
AU3294700A (en) Self-contained and mobile washstand for recurrent use in medical environment
EP1229924A4 (en) Targeted bifunctional molecules and therapies based thereon

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020506

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20021106

17Q First examination report despatched

Effective date: 20060524

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070519